gamma-Glutamylcysteine



Compound IDCDAMM00779
Common namegamma-Glutamylcysteine
IUPAC name2-amino-5-[(1-carboxy-2-sulfanylethyl)amino]-5-oxopentanoic acid
Molecular formulaC8H14N2O5S

Experimental data

Retention time0.27
Adduct[M+Na]+
Actual mz273.051
Theoretical mz273.051
Error0.07
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.8159

Identifiers and class information

Inchi keyRITKHVBHSGLULN-LXDRQGDMNA-N
SmilesO=C(O)C(N)CCC(=O)NC(C(=O)O)CS
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)9
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)250.269
Computed dipole moment(dipole)9.932
Total solvent accessible surface area (SASA)468.067
Hydrophobic component of SASA (FOSA)135.323
Hydrophilic component of SASA (FISA)259.716
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)73.028
Total solvent accesible volume (volume)776.487
Number of hydrogen bond donors (donorHB)4.25
Number of hydrogen bond acceptors (accptHB)6.25
Free energy of solvation of dipole (dip^2/V)0.127047
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0275275
Globularity descriptor (glob)0.872863
Predicted polarizability in cubic angstroms (QPpolrz)19.142
Predicted hexadecane/gas partition coefficient (QPlogPC16)8.712
Predicted octanol/gas partition coefficient (QPlogPoct)17.687
Predicted water/gas partition coefficient (QPlogPw)15.123
Predicted octanol/water partition coefficient (QPlogPo/w)-2.25
Predicted aqueous solubility (QPlogS)-0.223
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.187
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)0.674
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.325
Predicted brain/blood partition coefficient (QPlogBB)-1.674
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.661
Predicted skin permeability, log Kp (QPlogKp)-7.505
PM3 calculated ionization potential (IP(ev))9.546
PM3 calculated electron affinity (EA(eV))0.271
Number of likely metabolic reactions (#metab)6
Prediction of binding to human serum albumin (QPlogKhsa)-1.417
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)5.038
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)28.247
Van der Waals surface area (PSA)156.358
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29475NOS1Nitric-oxide synthase, brainT16117SEA
P35228NOS2Nitric oxide synthase, inducibleT02703SEA
P29474NOS3Nitric-oxide synthase, endothelialT06046SEA
P09960LTA4HLeukotriene A4 hydrolaseT03691SEA
O00222GRM8Metabotropic glutamate receptor 8T77548SEA
P08473MMENeprilysinT05409SEA
P43005SLC1A1Excitatory amino acid transporter 3T31721SEA
P39086GRIK1Glutamate receptor ionotropic kainate 1T73495SEA
Q13002GRIK2Glutamate receptor ionotropic kainate 2T58178SEA
O15303GRM6Metabotropic glutamate receptor 6T55956SEA
Q16478GRIK5Glutamate receptor ionotropic kainate 5T87930SEA
Q13003GRIK3Glutamate receptor ionotropic kainate 3T68876SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
Q07075ENPEPAminopeptidase AT31956SEA
Q01650SLC7A5L-type amino acid transporter 1 (by homology)T48330SEA
P49356FNTBFarnesyl protein transferaseT13127SEA
P09211GSTP1Glutathione S-transferase PiT21669SEA
P08263GSTA1Glutathione S-transferase A1T17221SEA
Q9BYF1ACE2Angiotensin-converting enzyme 2T27889SEA
P43003SLC1A3Excitatory amino acid transporter 1T86582SEA
Q9Y3Q0NAALAD2NAALADase IIT70036SEA
Q92820GGHGamma-glutamyl hydrolaseT71646SEA
Q04760GLO1Glyoxalase IT88285SEA
P09210GSTA2Glutathione S-transferase A2T53510SEA
Q04609FOLH1Glutamate carboxypeptidase IIT97071SEA
P09958FURHUMAN dibasic-processing enzymeT98945SEA
Q9Y4G9PCSK6Proprotein convertase subtilisin/kexin type 6T86503SEA
P00480OTCOrnithine transcarbamylaseT52098SEA
Q16348PEPT2Solute carrier family 15 member 2T52067SEA
P49356FNTBFarnesyl protein transferaseT13127SEA
Q92887CMOATMultidrug resistance-associated protein 2T61792SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16117DI0173Headache[ICD-11: 8A80-8A84]P29475NOS1
T16117DI0264Migraine[ICD-11: 8A80]P29475NOS1
T02703DI0083Chronic kidney disease[ICD-11: GB61]P35228NOS2
T02703DI0320Osteoarthritis[ICD-11: FA00-FA05]P35228NOS2
T02703DI0375Sepsis[ICD-11: 1G40-1G41]P35228NOS2
T02703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P35228NOS2
T06046DI0287Myocardial infarction[ICD-11: BA41-BA43]P29474NOS3
T03691DI0012Acute myeloid leukaemia[ICD-11: 2A60]P09960LTA4H
T05409DI0175Heart failure[ICD-11: BD10-BD1Z]P08473MME
T73495DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P39086GRIK1
T73495DI0396Substance abuse[ICD-11: 6C40]P39086GRIK1
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T31956DI0190Hypertension[ICD-11: BA00-BA04]Q07075ENPEP
T13127DI0342Premature ageing appearance[ICD-11: LD2B]P49356FNTB
T21669DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P09211GSTP1
T27889DI0009Acute diabete complication[ICD-11: 5A2Y]Q9BYF1ACE2
T27889DI0217Intrathoracic organs injury[ICD-11: NB32]Q9BYF1ACE2
T27889DI0356Pulmonary hypertension[ICD-11: BB01]Q9BYF1ACE2
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T97071DI0122Diagnostic imaging[ICD-11: N.A.]Q04609FOLH1
T97071DI0346Prostate cancer[ICD-11: 2C82]Q04609FOLH1
T98945DI0263Middle East Respiratory Syndrome[ICD-11: 1D64]P09958FUR
T52098DI0258Metabolism inborn error[ICD-11: 5C50]P00480OTC
T13127DI0342Premature ageing appearance[ICD-11: LD2B]P49356FNTB

Copyright © 2025